腹腔镜Heller肌切开术17年长期疗效:对POEM的挑战
平均随访17年,78.7%患者症状控制成功,但21.3%失败,主要因胃食管反流病;2.5%发生Barrett食管,3.7%发生鳞状细胞癌。作者建议术后定期内镜监测,并认为这些长期结果对POEM构成挑战。
要点
- 腹腔镜Heller肌切开术17年随访症状控制成功率为78.7%。
- 术后胃食管反流病症状发生率18.7%,Barrett食管2.5%。
- 术后鳞状细胞癌发生率3.7%,建议定期内镜监测。
核心结论
- 腹腔镜Heller肌切开术在术后17年仍能控制约79%贲门失弛缓症患者的症状,内镜、测压和功能研究证实了这一结果。
- 术后新发胃食管反流病症状者占18.7%,鳞状细胞癌发生于3.7%既往无症状的患者。
- 建议所有接受过手术的患者定期进行内镜监测,这些超长期结果对POEM内镜治疗构成真正挑战。
研究设计与样本
- 排除IV级患者、既往接受过手术或内镜治疗者以及巨大食管裂孔疝患者。
- 术后晚期进行放射学评估、两次带活检的内镜检查、测压评估和24小时pH监测。
主要发现
- 无手术死亡率和术后并发症,平均住院时间为两天。
- 9例患者(10.1%)失访,平均晚期随访时间为17年(10-26年)。
- Visick I和II级(成功)占78.7%,III-IV级(失败)占21.3%,主要归因于胃食管反流病。
- 测压评估显示下食管括约肌压力(LESP)显著且持续下降。
- 24小时pH监测在Visick I级患者中正常,在胃食管反流病患者中显示病理性酸反流。
临床怎么用
- 腹腔镜Heller肌切开术联合部分胃底折叠可作为贲门失弛缓症的标准手术选项,长期症状控制率约79%。
- 术后需关注胃食管反流病症状,Visick I级患者pH监测正常,而反流病患者显示病理性酸反流。
- 所有接受过手术的患者应定期进行内镜监测,以筛查Barrett食管和鳞状细胞癌。
局限性
- 9例患者(10.1%)失访,可能影响长期结果的完整性。
- 研究纳入1993年至2008年间患者,手术技术和围术期管理可能与当前实践存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Laparoscopic Heller Myotomy (LHM) with partial anterior or posterior fundoplication is the standard surgical procedure for treating achalasia patients. The results reported are mainly based on symptomatic evaluations and have less than 5 years of follow-up and none more than ten. OBJECTIVE: To determine the late results of LHM, performing endoscopic, histologic, manometric, and functional studies in addition to clinical evaluations. MATERIALS AND METHODS: Eighty-nine consecutive patients were included in a prospective study from 1993 to 2008. Inclusion criteria corresponded to achalasia patients with Types I to III (radiological evaluation). Exclusion criteria included patients with grade IV, patients with previous procedures (surgical or endoscopic), or giant hiatal hernia. They were submitted to a radiological evaluation, over two endoscopic procedures with biopsy samples, manometric assessments, and 24-h pH monitoring late after surgery. RESULTS: There was no operative mortality nor postoperative complications. The average hospital stay was two days. Nine patients (10.1%) were lost from follow-up. The mean late follow-up was 17 years (10-26). Visick I and II (success) corresponded to 78.7% of patients and grades III-IV (failure) to 21.3%, mainly due to gastroesophageal reflux disease (GERD). Manometric evaluations showed a significant and permanent decrease in lower esophageal sphincter pressure (LESP). 24-h pH monitoring was normal among Visick I patients and showed pathologic acid reflux in patients with GERD. Two patients (2.5%) developed Barrett's esophagus. Squamous-cell carcinoma (SCC) appeared in three patients (3.7%). CONCLUSION: LHM controlled symptoms in 79% of achalasia patients very late (17 years) after surgery. This was corroborated by endoscopic, manometric, and functional studies. GERD symptoms developed in 18.7% and SCC in 3.7% in previously asymptomatic patients. Endoscopic surveillance at regular intervals is recommended for all patients who have had surgery. These very long-term results are a real challenge to POEM endoscopic treatment. Unique Identifying Registration Number 3743.
引用
- Csendes A, Orellana O, Figueroa M, et al. Long-term (17 years) subjective and objective evaluation of the durability of laparoscopic Heller esophagomyotomy in patients with achalasia of the esophagus (90% of follow-up): a real challenge to POEM. Surg Endosc. 2021. PMID: 33471177. doi:10.1007/s00464-020-08273-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。